Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Early Restrictive or Liberal Fluid Management for Sepsis-induced Hypotension

Clinical question: What’s the effect of restrictive versus liberal fluid resuscitation strategies in sepsis-induced hypotension on 90-day mortality?

Background: Intravenous fluid resuscitation is the mainstay therapy for sepsis despite the vasodilatory nature of septic shock, and higher volumes may be associated with higher mortality with pathological edema.

Study design: Multicenter, randomized, unblinded, superiority trial

Setting: 60 U.S. centers from March 2018 to January 2022

Synopsis: 1,563 patients were enrolled, randomized to restrictive and liberal fluid resuscitation groups in a 1:1 ratio within four hours of sepsis-induced hypotension diagnosis, and followed for 24 hours. Patients were monitored for signs of tissue hypoperfusion with vital signs, lactic acid, and bedside echocardiographic monitoring. Lactated Ringers was the most common type of fluid administered, and norepinephrine was the first-line vasopressor. 90-day mortality point estimates in two treatment groups, compared using the Z test with Greenwood’s standard error and 95% Wald confidence interval, were found to be 14% in the restrictive group and 14.9% in the liberal group. The fluid difference between the groups was 2,134 ml with 59% vasopressor use in the restrictive group compared to 37.2% in the liberal group. A similar number of serious adverse events (21 and 19) were reported in both groups, along with three instances of potential vasopressor-related extravasation among 500 patients who received peripherally administered vasopressors.

Bottom line: In patients with sepsis-induced hypotension no significant difference in 90-day mortality was found among restrictive and liberal fluid resuscitation strategies. Secondary outcomes including the number of days free from ventilator, renal replacement therapy, vasopressor use, days out of intensive care unit and out of hospital were also comparable.

Citation: National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network, et al. Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med. 2023;388(6):499-510.

Dr. Pannu

Dr. Pannu is a hospitalist at Atrium Health Wake Forest Baptist, and an assistant professor in internal medicine at Wake Forest University School of Medicine, both in Winston-Salem, N.C

  • Early Restrictive or Liberal Fluid Management for Sepsis-induced Hypotension

    April 1, 2024

  • Moderate-intensity Statin With Ezetimibe Combination Therapy Versus High-intensity Statin Monotherapy in Patients at Very High Risk of ASCVD

    April 1, 2024

  • Aspirin or LMWH for Thromboprophylaxis After a Fracture

    April 1, 2024

  • Comparison of Standard Dose, High Dose, and Therapeutic Anticoagulation in Hypoxemic COVID-19 Patients

    April 1, 2024

  • Hydrocortisone in Severe CAP

    April 1, 2024

  • DOACs Versus Warfarin Across the Spectrum of Kidney Function

    April 1, 2024

  • Associations of Apixaban Dose with Safety and Effectiveness Outcomes in Patients with Atrial Fibrillation and Severe CKD

    April 1, 2024

  • Make the Most of Your Time at Converge 2024

    April 1, 2024

  • Working with Patient and Family Advisory Councils

    April 1, 2024

  • Top 10 Challenges to QIPs

    April 1, 2024

1 … 32 33 34 35 36 … 968
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences